With Hydrix having a personal interest in the success of MEM, I do hope we have a little more priority in production. Seems to me, at this stage, any delay to sales would be due to lack of engagement from the directors or marketing team with potential early access clients.
- Forums
- ASX - By Stock
- MEM
- Ann: Acceleration of reproductive biotechnology portfolio
Ann: Acceleration of reproductive biotechnology portfolio, page-6
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MEM (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.82M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2392219 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 11484 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2392219 | 0.008 |
7 | 6377999 | 0.007 |
7 | 2520583 | 0.006 |
3 | 1410000 | 0.005 |
4 | 2920833 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 11484 | 1 |
0.011 | 1617508 | 3 |
0.012 | 271782 | 2 |
0.014 | 188890 | 4 |
0.015 | 26002 | 3 |
Last trade - 10.04am 13/08/2024 (20 minute delay) ? |
Featured News
MEM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online